Back
Sage Therapeutics Stock Price Chart
Sponsored
SAGE
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
22
SAGE
Sage Therapeutics
Last Price:
7.51
Seasonality Move:
14.13%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing selling pressure, which indicates risk of future bearish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.6 | Sell |
20-day SMA: | 7.79 | Sell |
50-day SMA: | 9.09 | Sell |
200-day SMA: | 15.7 | Sell |
8-day EMA: | 7.63 | Sell |
20-day EMA: | 7.86 | Sell |
50-day EMA: | 8.87 | Sell |
200-day EMA: | 15.05 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 41.24 | Sell |
Chaikin Money Flow: | -375638 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.51 - 8.33) | Sell |
Bollinger Bands (100): | (8.49 - 12.15) | Sell |
Sage Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 7.50 while SAGE 8-day simple moving average is 7.60, which is a Sell signal.
- The stock price of SAGE is 7.50 while Sage Therapeutics 20-day SMA is 7.79, which makes it a Sell.
- Sage Therapeutics 50-day simple moving average is 9.09 while SAGE share price is 7.50, making it a Sell technically.
- SAGE stock price is 7.50 and Sage Therapeutics 200-day simple moving average is 15.70, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
22
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a Sell
The current Sage Therapeutics [SAGE] share price is $7.50. The Score for SAGE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
457.88M
Price in USD:
7.50
Share Volume:
459.11K
Sage Therapeutics 52-Week Range
52-Week High:
28.26
52-Week Low:
7.19
Sell
22
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?
The Sage Therapeutics stock price is 7.50 USD today. -
Will SAGE stock go up or go down?
Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sage Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 7.50 while SAGE 8-day exponential moving average is 7.63, which is a Sell signal.
- The stock price of SAGE is 7.50 while Sage Therapeutics 20-day EMA is 7.86, which makes it a Sell.
- Sage Therapeutics 50-day exponential moving average is 8.87 while SAGE share price is 7.50, making it a Sell technically.
- SAGE stock price is 7.50 and Sage Therapeutics 200-day simple moving average is 15.05, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.13 per share, an increase next quarter of $0.23 per share, an increase this year of $2.99 per share, and an increase next year of $1.38 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
- SAGE Moving Average Covergence Divergence (MACD) indicator is -0.36, suggesting Sage Therapeutics is a Sell
- Sage Therapeutics Relative Strength Index (RSI) is 41.24, which suggest Sage Therapeutics is oversold
- The Bollinger Bands (25) for Sage Therapeutics is (7.51 - 8.33), which suggest Sage Therapeutics is a Sell
- The Bollinger Bands (100) for Sage Therapeutics is (8.49 - 12.15), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.